44 results
6-K
EX-99.2
KMDA
Kamada Ltd
8 May 24
Report of Foreign Private Issuer
7:00am
or maintaining U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment
6-K
EX-99.2
KMDA
Kamada Ltd
6 Mar 24
Report of Foreign Private Issuer
7:10am
or maintaining U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment, restrains
6-K
EX-99.2
KMDA
Kamada Ltd
13 Nov 23
Report of Foreign Private Issuer
7:00am
Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment, restrains related to third parties’ IP
6-K
EX-99.2
KMDA
Kamada Ltd
16 Aug 23
Report of Foreign Private Issuer
7:00am
Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment, restrains related to third parties’ IP
6-K/A
EX-99.2
avyk6eioora ew8
24 May 23
Current report (foreign) (amended)
4:05pm
6-K
EX-99.2
t6imj
24 May 23
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates
8:00am
6-K/A
EX-99.1
pefuibgf uklm
17 Nov 22
Current report (foreign) (amended)
1:08pm
6-K
EX-99.1
2v8e6
8 Nov 22
Notice of Annual General Meeting of Shareholders
7:02am
6-K
EX-99.2
2yz6gdywi u3
22 Nov 21
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
y2w29cv 2mwwb4b
12 May 21
Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development Activities
7:06am
6-K
EX-99.1
ox4qj6no7vvhgs3la
10 Feb 21
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
7:00am
6-K
EX-99.1
pw1us8e7qlpt
29 Oct 20
Report of Foreign Private Issuer
5:00pm
6-K
EX-99.1
kk3shry6ictft6unt79
13 Feb 20
Report of Foreign Private Issuer
11:06am